Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01504568

The Use of Prophylactic Antibiotics in Isolated Blowout Fractures

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

The purpose of the research is to perform a quality assurance evaluation using randomized prospective analysis the rate of orbital cellulitis as a complication of nonsurgical orbital blowout fracture in patients treated versus not treated with prophylactic antibiotics. The investigators goal is to show the use of prophylactic antibiotics in orbital blowout fractures does not significantly decrease the rate of orbital cellulitis and is thus not indicated.

Detailed description

Orbital fractures are a common occurrence in association with a wide variety of blunt trauma injuries to the face. One type of fracture is that involving the orbital floor, or an isolated blowout fracture. One common current practice is to use prophylactic antibiotics in these cases to prevent the theoretical occurrence of an orbital cellulitis originating from sinus flora, though there is no current standard of care regarding this practice. Many surgeons may elect to not use antibiotics for this very reason. The use of prophylactic antibiotics in isolated blowout fractures where there is no occlusion of the ostium is not defined, and no prospective controlled study has been undertaken to suggest the most appropriate course of action to take. Our goal in this study is to determine a correct course of action for these patients.

Conditions

Interventions

TypeNameDescription
OTHERTreatmentAdults: ≥40 kg:250mg every eight hours Children: \<40kg: 20mg/kg/day divided in three doses (up to 250mg) every eight hours Suspension form 250mg/ml

Timeline

Start date
2012-01-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2012-01-05
Last updated
2012-11-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01504568. Inclusion in this directory is not an endorsement.